![M3DIMAKER 1 image M3dimaker 1 image](../../../assets/images/homeFIrst.jpg)
Pharmaceutical 3D Printing for Personalised Medicine
FABRX provides pharmaceutical 3D printers, software, and pharma-ink development services for personalised medicine and small batch manufacture, ideal for drug development and clinicals trials.
![M3DIMAKER 1 image M3dimaker 1 image](../../../assets/images/homeFIrst.jpg)
![FABRX provided product and services FABRX provided product and services](../../../assets/images/new_products_and_services.png)
Pharmaceutical 3D Printer
The M3DIMAKER is the world's first GMP-ready pharmaceutical 3D printer series with in-built quality control features and exchangeable printheads for fully personalised human and veterinary precision medicine manufacture.
Our printers can be used under extemporaneous/compounding preparation regulation using standard pharmaceutical excipients. Available to purchase or rent.
Software
Personalised prescriptions with just a few button clicks; our comprehensive, easy-to-use M3DIMAKER Studio software packages can be used to control the printer, ensure quality and collect patient feedback, providing simplified workflows and data management.
Printlets™ & Pharma-inks
Our world leading scientists can help you design, develop and test 3D printable pharma-inks for your chosen active ingredients, as well as manufacture small batches of novel medication for clinical trials.
Research & Pharma-ink development
FABRX is involved in a number of projects for personalised medicine with hospitals, universities and pharmaceutical companies. In the next few years, we will have hundreds of pharma-ink protocols that can be implemented into compounding workflows for a range of drugs and treatment pathways, to be prepared by the pharmacist or supplied as pre-filled cartridges for simplified workflows. Below is a pipeline reflecting some of our current projects in a variety of disease and therapeutics areas.
Early Stage
Formulation Development
Preclinical Stage
Clinical Stage
Oncology
Rare diseases
Metabolic disorders
Transplants
Nutraceuticals
Research
FABRX is involved in a number of projects for personalised medicine with research organisations, universities and pharmaceutical companies to develop novel dosage forms using pharmaceutical 3D printing. Below is a pipeline of our current projects in a variety of disease and therapeutics areas.
Early Stage
Formulation Development
Preclinical Stage
Clinical Stage
Oncology
Rare diseases
Metabolic disorders
Transplants
Nutraceuticals
We have collaborators and printers around the world
![Map locations Map locations](../../../assets/images/mapLocations.jpg)
![UCL logo UCL logo](../../../assets/images/partners/Imagen1.png)
![gustave roussy logo gustave roussy logo](../../../assets/images/partners/Imagen2.jpg)
![3D limitless logo 3D limitless logo](../../../assets/images/partners/Imagen3.jpg)
![Innovate UK logo Innovate UK logo](../../../assets/images/partners/Imagen5.png)
![EPSRC logo EPSRC logo](../../../assets/images/partners/Imagen6.png)
![Basesoft logo Basesoft logo](../../../assets/images/partners/Imagen7.jpg)
![ULisboa logo ULisboa logo](../../../assets/images/partners/Imagen8.png)
![CDC logo CDC logo](../../../assets/images/partners/Imagen9.png)
![Losan Pharma logo Losan Pharma logo](../../../assets/images/partners/Imagen10.png)
![University of Cambridge logo University of Cambridge logo](../../../assets/images/partners/Imagen11.png)
![Vall D'Hebron logo Vall D'Hebron logo](../../../assets/images/partners/Imagen12.png)
![ULimerick logo ULimerick logo](../../../assets/images/partners/Imagen13.jpg)
![RNIB logo RNIB logo](../../../assets/images/partners/Imagen14.png)
![ULaguna logo ULaguna logo](../../../assets/images/partners/Imagen15.jpg)
![UBrunel log UBrunel log](../../../assets/images/partners/Imagen16.png)
![Heidelberg logo Heidelberg logo](../../../assets/images/partners/Imagen32.png)
![Hamburg logo Hamburg logo](../../../assets/images/partners/Imagen33.png)
![Kaunas Univ logo Kaunas Univ logo](../../../assets/images/partners/Imagen34.png)
![UCL logo UCL logo](../../../assets/images/partners/Imagen1.png)
![gustave roussy logo gustave roussy logo](../../../assets/images/partners/Imagen2.jpg)
![3D limitless logo 3D limitless logo](../../../assets/images/partners/Imagen3.jpg)
![Innovate UK logo Innovate UK logo](../../../assets/images/partners/Imagen5.png)
![EPSRC logo EPSRC logo](../../../assets/images/partners/Imagen6.png)
![Basesoft logo Basesoft logo](../../../assets/images/partners/Imagen7.jpg)
![ULisboa logo ULisboa logo](../../../assets/images/partners/Imagen8.png)
![CDC logo CDC logo](../../../assets/images/partners/Imagen9.jpg)
![Losan Pharma logo Losan Pharma logo](../../../assets/images/partners/Imagen10.png)
![University of Cambridge logo University of Cambridge logo](../../../assets/images/partners/Imagen11.png)
![Vall D'Hebron logo Vall D'Hebron logo](../../../assets/images/partners/Imagen12.png)
![ULimerick logo ULimerick logo](../../../assets/images/partners/Imagen13.jpg)
![RNIB logo RNIB logo](../../../assets/images/partners/Imagen14.png)
![ULaguna logo ULaguna logo](../../../assets/images/partners/Imagen15.jpg)
![UBrunel log UBrunel log](../../../assets/images/partners/Imagen16.png)
![Heidelberg logo Heidelberg logo](../../../assets/images/partners/Imagen32.png)
![Hamburg logo Hamburg logo](../../../assets/images/partners/Imagen33.png)
![Kaunas Univ logo Kaunas Univ logo](../../../assets/images/partners/Imagen34.png)
![UMonash logo UMonash logo](../../../assets/images/partners/Imagen17.png)
![Evonik logo Evonik logo](../../../assets/images/partners/Imagen18.png)
![UBradford logo UBradford logo](../../../assets/images/partners/Imagen19.png)
![UFRGS logo UFRGS logo](../../../assets/images/partners/Imagen20.png)
![Astra Zeneca logo Astra Zeneca logo](../../../assets/images/partners/Imagen21.png)
![Manguinhos logo Manguinhos logo](../../../assets/images/partners/Imagen22.jpg)
![Nisso logo Nisso logo](../../../assets/images/partners/Imagen23.png)
![Gatefosse logo Gatefosse logo](../../../assets/images/partners/Imagen24.jpg)
![Pfizer logo Pfizer logo](../../../assets/images/partners/Imagen25.png)
![UDC logo UDC logo](../../../assets/images/partners/Imagen26.png)
![IntractPharma logo IntractPharma logo](../../../assets/images/partners/Imagen27.jpg)
![Fiocruz logo Fiocruz logo](../../../assets/images/partners/Imagen28.jpg)
![Sergas logo Sergas logo](../../../assets/images/partners/Imagen29.png)
![UPorto logo UPorto logo](../../../assets/images/partners/Imagen30.png)
![USC logo USC logo](../../../assets/images/partners/Imagen31.jpg)
![Maryland univ logo Maryland univ logo](../../../assets/images/partners/Imagen35.png)
![Erasmus mc logo Erasmus mc logo](../../../assets/images/partners/Imagen36.png)
![Alicante hospital Univ logo Alicante hospital Univ logo](../../../assets/images/partners/Imagen37.png)
![UMonash logo UMonash logo](../../../assets/images/partners/Imagen17.png)
![Evonik logo Evonik logo](../../../assets/images/partners/Imagen18.png)
![UBradford logo UBradford logo](../../../assets/images/partners/Imagen19.png)
![UFRGS logo UFRGS logo](../../../assets/images/partners/Imagen20.png)
![Astra Zeneca logo Astra Zeneca logo](../../../assets/images/partners/Imagen21.png)
![Manguinhos logo Manguinhos logo](../../../assets/images/partners/Imagen22.jpg)
![Nisso logo Nisso logo](../../../assets/images/partners/Imagen23.png)
![Gatefosse logo Gatefosse logo](../../../assets/images/partners/Imagen24.jpg)
![Pfizer logo Pfizer logo](../../../assets/images/partners/Imagen25.png)
![UDC logo UDC logo](../../../assets/images/partners/Imagen26.png)
![IntractPharma logo IntractPharma logo](../../../assets/images/partners/Imagen27.jpg)
![Fiocruz logo Fiocruz logo](../../../assets/images/partners/Imagen28.jpg)
![Sergas logo Sergas logo](../../../assets/images/partners/Imagen29.png)
![UPorto logo UPorto logo](../../../assets/images/partners/Imagen30.png)
![USC logo USC logo](../../../assets/images/partners/Imagen31.jpg)
![Maryland univ logo Maryland univ logo](../../../assets/images/partners/Imagen35.png)
![Erasmus mc logo Erasmus mc logo](../../../assets/images/partners/Imagen36.png)
![Alicante hospital Univ logo Alicante hospital Univ logo](../../../assets/images/partners/Imagen37.png)